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1. INTRODUCTION 
Biliary release of glutathione disulfide (GSSG) 
and glutathione-S-conjugates by the isolated per- 
fused liver under different metabolic conditions 
has been studied by several investigators [l-3]. 
Sies et al. [ 1,3] have shown that efflux of GSSG oc- 
curs during oxidation of drugs such as hexobarbi- 
tal and ethylmorphine as well as during hydro- 
peroxide metabolism. In the isolated liver there is 
also a transport of reduced glutathione (GSH) into 
the perfusate space [4]. However, it has also been 
reported that relatively high concentrations of 
GSH may be excreted in the bile produced in situ 
]5a,bl. 
The present study, performed mainly with iso- 
lated perfused rat liver, concerns the release of 
both reduced and oxidized glutathione in bile after 
arsenite exposure. It has previously been shown 
that arsenic is eliminated via this route [6] and 
compounds such as selenite are known to interact 
with arsenite in a way that increases their respec- 
tive elimination in the bile [7,8]. Furthermore, the 
form of As, e.g., if complexed to small molecular 
weight compounds, or the mechanism(s) involved 
in its biliary excretion, have not been described. 
Similar studies have indicated an involvement of 
GSH in the excretion of zinc and other metals 
[9,10] in rat bile in situ. 
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2. MATERIALS AND METHODS 
Perfusions were performed with livers from 
male Sprague-Dawley rats (200-230 g). The ani- 
mals had food and water ad libitum. Chemicals 
used were at least of reagent grade and purchased 
from local commercial sources. 
A recirculating perfusion system was used [l l] 
and the perfusate (100 ml) was Krebs-Henseleit 
buffer supplemented with 25 mM Hepes (N-2-hy- 
droxyethylpiperazine-N’-2-ethane sulphonic acid), 
pH 7.4, and saturated with an oxygen-carbon 
mixture (95:5). Perfusate flow was maintained at 
3.5-5 ml/min and g liver and the pressure was 20 
cm H20. After an equilibration period of 15-20 
minutes, bile was collected at ten minute intervals 
for 1 h. Aliquots of bile were deproteinized with 
metaphosphoric acid immediately after collection 
and stored on ice until assayed at the end of the 
experiment. Arsenite was usually added to the per- 
fusate at 30 min. [74As]arsenite, prepared by re- 
duction of [74As]arsenic acid (Amersham, Eng- 
land) with sulphite [ 121, was added to the perfusate 
(about 0.5 &i/ 100 ml). The bile flow was 6- 10 pl/ 
min. It was increased to about the double volume 
when arsenite was added, and then decreased to- 
wards control values at the end of the perfusion. 
The liver retained its normal macroscopic ap- 
pearance, and the activity of lactate dehydro- 
genase in the perfusate was unchanged during a 60 
min perfusion. 
GSH and GSSG were assayed fluorimetrically 
[ 131 in the bile and in portions of the liver after de- 
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proteination. A method based on high perfor- 
mance liquid chromatography was also used to as- 
say GSH and GSSG in the bile [14]. Sulfobromo- 
phtalein (BSP) was measured at 578 nm after dilu- 
tion of bile samples with 0.1 M sodium hydroxide 
[ 151. Thin-layer chromatography of bile aliquots 
was performed on cellulose plates using a solvent 
system of isobutyric acid/N&OH/H20 (66:33: 1, 
by vol.). Spots containing radioactivity were identi- 
fied with photographic film. 
3. RESULTS AND DISCUSSION 
In agreement with previous reports on hemo- 
globin free perfusions [ 1,3,4] only small amounts 
of GSH was excreted in bile ( -0.03 nmol . g 
liver-l . min-I) under control conditions. As 
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Fig.1. Content of GSH in bile from isc )la ted rat liver 
perfused with different concentrations of arsenite. Arse- 
nite was added at 30 min. Bars indicate mean f SE of 
4-6 separate experiments and show the amount of GSH 
excreted during three 10 min intervals. 
Time, min 
Fig.2. Accumulated amount of GSH released in bile 
after arsenite addition: (A) arsenite (1 pmol) added at 10 
min; (e) three doses of arsenite (1 pmol) added at 10, 20 
and 30 min. Values are mean of three experiments. 
shown in fig.1 the amount of GSH increased in 
bile after arsenite addition. The amount recovered 
after 30 min was related to the amount of arsenite 
added and with increasing concentrations of arse- 
nite, bile flow rates also increased (table 1). The 
GSH concentration in bile was also dependent on 
the time elapsed after the addition of arsenite. In 
the samples taken during the last 10 min of perfu- 
sion less GSH was detected than in the samples 
taken during lo-20 min. When repeated doses of 
arsenite were administered at lo-min intervals the 
biliary GSH concentration remained high for a 
longer period, and the amount recovered after 30 
min of perfusion with arsenite was more than dou- 
bled, as compared to the effect of a single dose 
(fig.2). It thus seems as arsenite stimulated GSH 
release in bile only during a certain phase of its 
metabolism. This interpretation is compatible with 
the results obtained by Klaassen [6], who showed 
that, after a single dose of arsenite, biliary excre- 
tion of As occurred mainly during the first 15 min. 
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Table 1 
Amount of glutathione and arsenic excreted into the bile and hepatic glutathione content of 
perfused rat liver 
Additions nmol arsenic GSH GSSG GSH + Bile flow Hepatic GSH contentC 
excreted in 2 GSSG @Urnin) (pmollg liver) 
bile/30 min 
X g liver 
(nmol excreted in bile/ 
30 min X g liver) 
1 pm01 arsenite _a 25 46 117 720.7 5.7 
2.5 pm01 arsenite 20 118 72 262 9.2 r0.4 5.55 1.0 
5 pm01 arsenite 52 257 90 438 11.42 1.3 4.7+ 1.2 
10 pm01 arsenite _a 342 100 543 12.52 1.2 3.6kO.7 
5 pm01 seleniteb + 
5 pm01 arsenite 241 122 485 
a Not determined 
b 5 pm01 selenite was added 10 min prior to the addition of arsenite 
C GSH was assayed in the liver at the end of perfusion 
Experiments were performed with radiolabelled arsenite as described in Materials and Methods. 
Values depicted are mean + SE of 3-6 experiments. 
The decreased biliary excretion was related to a re- part of it may have been retained in the liver in a 
distribution and binding of hepatic As. not readily detectable form. 
The study on in situ produced rat bile [5] indi- 
cates GSH efflux under physiological conditions. 
We repeated some of these experiments and the 
concentration of GSH was found to be approx- 
imately 1.2 mM. When arsenite was injected in the 
tail vein (10 pmol/kg rat) the concentration of 
GSH in bile was more than 4-fold increased dur- 
ing the first 20 min. 
Other possible effects of arsenite on glutathione 
turnover were also studied. The amount of GSSG 
excreted in the bile under control conditions was 
0.7-0.9 nmol/min g liver which is slightly less than 
previously reported [4]. During perfusion with ar- 
senite the biliary GSSG content increased (table 1) 
while the amount in the perfusate was only slightly 
raised (not shown). The amount of GSH in the 
perfusate did not increase over control levels. 
There was no consistent stoichiometric relationship 
between the amounts of GSH and GSSG, but to 
what extent oxidation of GSH in the bile affected 
the values given in table 1 is not known. It has 
been claimed that this may occur rapidly in bile 
[5]. However, the total amount of glutathione, re- 
covered in bile (table 1) was always less than the 
amount apparently lost in the liver indicating that 
As could be expected from a previous study [8] 
about 10% of a given dose of arsenite (when given 
as 74As) was recovered in the bile after 30 min 
(table 1). Thin-layer chromatography of the bile 
showed that the major part of 74As was associated 
with a ninhydrin positive spot eluting together 
with GSSG. No radioactivity was associated with 
GSH. These results, as well as the fact that as 
much as 10 mol of glutathione was detected per 
mole of arsenite in the bile, indicate that at least 
part of GSH was excreted as such. 
1 pmol arsenite did not markedly affect BSP ex- 
cretion in bile, while 2.5 pm01 and 10 pm01 of arse- 
nite decreased BSP excretion in a dose dependent 
fashion (lig.3). This may reflect a competition for a 
common excretion mechanism for biliary products 
(cf[Wh 
If GSH is excreted in bile xenobiotic conjugates 
may form already in the intestinal umen. Such an 
interaction may lead to inactivation and/or a de- 
layed absorption of ingested compounds. In an 
effort to substantiate these thoughts selenite was 
also tested, as this compound is of nutritional im- 
portance and has been shown to readily react with 
GSH to form poorly absorbed metabolites [17,181. 
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